Glipizide Tablet
Product Images NDC 71610-175

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 71610-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 5 mg (71610 0175 60)

Label for Glipizide USP 5 mg tablets, packaging 90 tablets. The label shows the NDC 71610-0175-60 and indicates the manufacturer as Apotex Inc., Toronto, Canada, with repackaging by Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN. Storage instructions and warnings are partially visible, along with batch and lot numbers.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Glipizide-structure.jpg (Glipizide Structure)

Chemical structure diagram of the active ingredient Glipizide showing its molecular arrangement, including heterocyclic rings and functional groups relevant to its chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.